Skip to main content
SpringerLink
Log in

Refillable Devices for Therapy of Ophthalmic Diseases

  • Chapter
  • First Online:
Book cover Drug Product Development for the Back of the Eye

Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series ((AAPS,volume 2))

Abstract

As a subset of ophthalmic drug delivery systems, refillable approaches encompass a relatively new but growing field of study. This review will cover general design considerations in the development of refill devices for the eye. This will include acceptability of administration sites, body and injection port design, influences of vacuum and pressure, flushing and fluid replacement for active, passive and solid delivery devices, and potential for contamination. Historical influences leading to the current design concepts such as development of parenteral infusion pumps, glaucoma drainage devices, and pioneering ocular experiments will be discussed. Finally, specific studies and designs on refillable systems that have been proposed to deliver agents either to the vitreous through the pars plana, via trans-scleral delivery from episcleral implantation, to subretinal or suprachoroidal spaces from anterior location or to the anterior or posterior chambers from the lens capsule will be presented.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adamis AP, Miller JW, Mescher MJ, Gragoudas ES, Borenstein JT (2004) Transscleral drug delivery device and related methods. Patent Cooperation Treaty International Publication Number WO 2004/073551 A2

    Google Scholar 

  • Adler N (1964) Use of self-sealing elastomer septums for quantitative operations with volatile solvents. Anal Chem 36(12):2291–2295

    Article  Google Scholar 

  • Ashton P, Patchell RA, Cooper J, Young BA (1998) Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body. US Patent 5,836,935

    Google Scholar 

  • Avery RL (2006) Implantable delivery device for administering pharmacological agents to an internal portion of a body. US Patent Application 20060258994 A1

    Google Scholar 

  • Avery RL, Luttrull JK (1998) Intravitreal medicine delivery. US Patent 5,830,173

    Google Scholar 

  • Avery RL, Saati S, Journey M, Caffey S, Varma R, Tai Y-C, Humayun MS (2010) A novel implantable refillable pump for intraocular drug delivery. Invest Ophthalmol Vis Sci 51, ARVO 2010 annual meeting, E-Abs 3799

    Google Scholar 

  • Bishop CJ, Sant HJ, Molokhia SA, Burr RM, Gale BK, Ambati BK (2010) Designing and manufacturing a refillable multi-drug capsule ring platform. Inv Ophthalmol Vis Sci 51, ARVO 2010 annual meeting, E-Abs A259

    Google Scholar 

  • Buchwald H, Grage TB, Vassilopoulos PP, Rohde TD, Varco RL, Blackshear PJ (1980) Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 45(5):866–869

    Article  PubMed  CAS  Google Scholar 

  • Cohen AM, Wood WC, Greenfield A, Waltman A, Dedrick C, Blackshear PJ (1980) Transbrachial hepatic arterial chemotherapy using an implanted infusion pump. Dis Colon Rectum 23(4):223–227

    Article  PubMed  CAS  Google Scholar 

  • Cohen AM, Greenfield A, Wood WC, Waltman A, Novelline R, Athanasoulis C, Schaeffer NJ (1983a) Treatment of hepatic metastases by transaxillary hepatic artery chemotherapy using an implanted drug pump. Cancer 51(11):2013–2019

    Article  PubMed  CAS  Google Scholar 

  • Cohen AM, Kaufman SD, Wood WC, Greenfield AJ (1983b) Regional hepatic chemotherapy using an implantable drug infusion pump. Am J Surg 145(4):529–533

    Article  PubMed  CAS  Google Scholar 

  • Dahlin DC, Trawick D, Zilliox P, Robertson SM, Sanders M, Struble C, Clark AF (2003) Design of a specialized cannula for posterior juxtascleral delivery of anecortave acetate to the retina for treatment CNV associated with age-related macular degeneration (AMD). Invest Ophthalmol Vis Sci 4, E-Abs 5036

    Google Scholar 

  • Dalton MJ (1989) Matrix septum. US Patent 4,857,053

    Google Scholar 

  • Dario A, Scamoni C, Picano M, Fortini G, Cuffari S, Tomei G (2005) The infection risk of intrathecal drug infusion pumps after multiple refill procedures. Neuromodulation 8(1):36–39

    Article  Google Scholar 

  • De Carvalho RAP, Krause ML, Murphree AL, Schmitt EE, Campochiaro PA, Maumenee IH (2006) Delivery from episcleral exoplants. Inv Ophthalmol Vis Sci 47:4532–4539

    Article  Google Scholar 

  • DeCarvalho RAP, Murphree AL, Schmitt EE (2003) Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues. US Patent Application 2003/0064088 A1 and PCT WO 03/020172

    Google Scholar 

  • DeCarvalho RAP, Krause ML, e Silva RL, Maumenee IH, Campochiaro P (2005) Transscleral diffusion patterns and intraocular tracer kinetics of sealable and refillable episcleral drug delivery systems. Inv Ophthalmol Vis Sci 46, E-Abs 3532

    Google Scholar 

  • Dinius HB, Huizenga JR (1984) Implant system. US Patent 4,451,254

    Google Scholar 

  • Doan P, Nettecoven WS (1992) Drug administration device over full protection valve. US Patent 5,158,547

    Google Scholar 

  • Franklin A (2007) Trans-scleral drug delivery method and apparatus. US Patent 7,276,050 B2

    Google Scholar 

  • Ginggen A (2009) Implantable pump with integrated refill detection. US Patent 7,637,897 B2

    Google Scholar 

  • Greenberg R (2009) Implantable drug delivery device. US Patent 7,527,621 A1 and US Patent Application 2002/0188282 A1

    Google Scholar 

  • Humayan M, De Juan E (2006) Reservoirs with subretinal cannula for subretinal drug delivery. US Patent Publication 2006/0200097 A1

    Google Scholar 

  • Krause M, e Silva RL, Maumenee IH, Campochiaro P, Schmitt EE, Murphree AL, de Carvalho RAP (2005) Characterization and validation of refillable episcleral drug delivery devices for unidirectional and controlled transscleral drug delivery. Inv Ophthalmol Vis Sci 46, E-Abs 499

    Google Scholar 

  • Levy R (1997) Implanted drug delivery systems for control of pain. Chapter 19. Neurosurgical management of pain. Springer, New York

    Google Scholar 

  • Levy A (2004) Self resealing elastomeric closure. US Patent 6,752,965 B2

    Google Scholar 

  • Li P-Y, Shih J, Lo R, Saati S, Agrawal R, Humayun MS, Tai Y-C, Meng E (2008) An electrochemical intraocular drug delivery device. Sens Actuators A 143:41–48

    Article  Google Scholar 

  • Lim KS, Allan BDS, Lloyd AW, Muir A, Khaw PT (1998) Glaucoma drainage devices; past, present and future. Br J Ophthalmol 82:1083–1089

    Article  PubMed  CAS  Google Scholar 

  • Liu HS, Refojo MF, Perry HD, Albert DM (1979) Sustained release of BCNU for the treatment of intraocular malignancies in animal models. Invest Ophthalmol Vis Sci 18:1061–1067

    PubMed  CAS  Google Scholar 

  • Liu LHS, Refojo MF, Ni C, Ueno N, Albert DM (1983) Sustained release of carmustine (BCNU) for treatment of experimental intraocular malignancy. Br J Ophthalmol 67:479–484

    Article  PubMed  CAS  Google Scholar 

  • Lo R, Li P-Y, Saati S, Agrawal RN, Humayun MS, Meng E (2009) A passive MEMS drug delivery pump for treatment of ocular diseases. Biomed Microdevices 11:959–970

    Article  CAS  Google Scholar 

  • Meng E, Humayun M, Lo R, Li P-Y, Saati S (2009) Implantable drug-delivery devices and apparatus and methods for refilling the devices. US Patent Application 20090192493

    Google Scholar 

  • Molokhia SA, Sant HJ, Hanson MC, Burr RM, Poursaid AE, Bishop CJ, Simonis JM, Gale BK, Ambati BK (2009) New intraocular drug delivery device. Inv Ophthalmol Vis Sci 50, ARVO 2009 annual meeting, E-Abs A597

    Google Scholar 

  • Molokhia SA, Sant H, Simonis J, Bishop CJ, Burr RM, Gale BK, Ambati BK (2010a) The capsule drug device: novel approach for drug delivery to the eye. Vis Res 50(7):680–685

    Article  PubMed  CAS  Google Scholar 

  • Molokhia SA, Burr RM, Sant HJ, Simonis JM, Gale BK, Ambati BK (2010b) In vivo pharmacokinetics of a new intraocular drug delivery device. Inv Ophthalmol Vis Sci 51, ARVO 2010 annual meeting, E-Abs A256

    Google Scholar 

  • Molteno ACB (1969) New implant for drainage in glaucoma. Animal trial. Br J Ophthalmol 53:161–168

    Article  PubMed  CAS  Google Scholar 

  • Muller H, Aigner K, Worm I, Lobisch M, Brahler A, Hempelmann G (1984) Long term experiences with continuous peridural opiate analgesia with an implanted pump. Anaesthesist 33(9):433–439

    PubMed  CAS  Google Scholar 

  • Olsen JM (2000) Overfill protection systems for implantable drug delivery devices. US Patent 6,152,898

    Google Scholar 

  • Olsen TW, Feng X, Wabner K, Conston SR, Sierra DH, Folden DV, Smith ME, Cameron JD (2006) Cannulation of the suprachoroidal space:  a novel drug delivery methodology to the posterior segment. Am J Ophthalmol 142(5):777–787

    Article  PubMed  CAS  Google Scholar 

  • Pang C, Jiang F, Shih J, Caffey S, Humayun M, Tai Y-C (2010) Drug-delivery pumps and methods of manufacture. US Patent Application 20100004639

    Google Scholar 

  • Peyman GA (2005) Ocular drug delivery. US Patent Publication 2005/0181018 A1

    Google Scholar 

  • Phillips TW, Chandler WF, Kindt GW, Ensminger WD, Greenberg HS, Seeger JF, Doan KM, Gyves JW (1982) New implantable continuous administration and bolus dose intracarotid drug delivery system for the treatment of malignant gliomas. Neurosurgery 11(2):213–218

    Article  PubMed  CAS  Google Scholar 

  • Prestele K, Funke H, Moschi R, Reif E, Franetzki M (1983) Development of remotely controlled implantable devices for programmed insulin infusion. Life Support Syst 1(1):23–38

    PubMed  CAS  Google Scholar 

  • Refojo MF, Liu HS (1981) Method for treating intraocular malignancies. US Patent 4,300,557

    Google Scholar 

  • Refojo MF, Liu HS, Leong FL, Sidebottom D (1978) Release of a nitrosourea derivative from refillable silicone rubber implants for the treatment of intraocular malignancies. J Bioeng 2(5):437–445

    PubMed  CAS  Google Scholar 

  • Renard E, Rostane T, Carriere C, Marchandin H, Jacques-Apostol D, Lauton D, Gibert-Boulet F, Bringer J (2001) Implantable insulin pumps: infections most likely due to seeding from skin flora determine severe outcomes of pump-pocket seromas. Diabetes Metab 27(1):62–65

    PubMed  CAS  Google Scholar 

  • Roorda WE (2001) Refillable implantable drug delivery pump. US Patent 6,283,949 B1

    Google Scholar 

  • Saati S, Lo R, Li P-Y, Meng E, Varma R, Humayun MS (2009) Mini drug pump for ophthalmic use. Trans Am Ophthalmol Soc 107:60–70. Subsequently reviewed, modified and re-published in 2010 Curr Eye Res 35(3):192–201

    Google Scholar 

  • Sassa R, Dove K, Cooper S (2009) Barrier with low extractables and resealing properties. US Patent Application 20090196798 A1

    Google Scholar 

  • Selam JL, Slingeneyer A, Chaptal PA, Franetzki M, Prestele K, Mirouze J (1982) Total implantation of a remotely controlled insulin minipumps in a human insulin dependant diabetic. Artif Organs 6(3):315–319

    Article  PubMed  CAS  Google Scholar 

  • Setabutr P, Bell NP, Feldman RM (2006) Intraoperative management of non-functioning Ahmed glaucoma valve implant. Ophthal Surg Lasers Imaging 37:62–64

    Google Scholar 

  • Slakter JS, Singerman LJ, Yannuzzi LA, Russell SR, Hudson HL, Jerdan J, Zilliox P, Robertson SM (2002) Sub-Tenon’s administration of the angiostatic agent anecortave acetate in AMD patients with subfoveal choroidal neovascularization (CNV) – the clinical outcome. Invest Ophthalmol Vis Sci 43, E-Abs 2909

    Google Scholar 

  • Varner SE, DeJuan E Jr, Shelley T, Barnes AC, Cooney MJ, Shelley TH (2002) Reservoir device for intraocular drug delivery. Patent Cooperation Treaty (PCT) International Publication No WO 02/100318

    Google Scholar 

  • Varner SE, DeJuan E Jr, Shelley T, Barnes AC, Humayun M (2004) Devices for intraocular drug delivery. US Patent 6,7196750 B2

    Google Scholar 

  • Watson DA, Shimizu RW, LaPorte R (2005) Implantable refillable and ported controlled release drug delivery device. US Patent 6,852,106 B2

    Google Scholar 

  • Weiner AL (2007) Drug delivery systems in ophthalmic applications. In: Yorio T, Clark A, Wax M (eds) Ocular therapeutics; eye on new discoveries. Academic, New York, pp 7–43

    Google Scholar 

  • Weiner AL, Sinnett K, Johnson S (1995) Tack for intraocular drug delivery and method for inserting and removing the same. US Patent 5,466,233

    Google Scholar 

  • Wong VG, Hu MWL, Berger DE Jr (2001) Controlled-release biocompatible ocular drug delivery implant devices and methods. US Patent 6,331,313 B1

    Google Scholar 

  • Yaacobi Y (2002) Ophthalmic drug delivery device. US Patent 6,416,777 B1

    Google Scholar 

  • Yaacobi Y (2006a) Ophthalmic drug delivery device. US Patent 6,986,900 B2

    Google Scholar 

  • Yaacobi Y (2006b) Ophthalmic drug delivery device. US Patent 7,094,226 B2

    Google Scholar 

  • Yaacobi Y, Chastain J, Lowseth L, Bhatia R, Slovin E, Rodstrom R, Stevens L, Dahlin D, Marsh D (2003) In-vivo studies with trans-scleral anecortave acetate delivery device designed to treat Choroidal neovascularization in AMD. Invest Ophthalmol Vis Sci 44, E-Abs 4210

    Google Scholar 

  • Yamamoto R, Conston SR, Sierra D (2007) Apparatus and formulations for suprachoroidal drug delivery. US Patent Publication 2007/0202186 A1

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. DrugDel Consulting, LLC, 173752, Arlington, TX, 76003, USA

    Alan L. Weiner PhD

Authors
  1. Alan L. Weiner PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alan L. Weiner PhD .

Editor information

Editors and Affiliations

  1. School of Pharmacy, University of Colorado Denver, East 17th Avenue 12631, Aurora, 80045, Colorado, USA

    Uday B. Kompella

  2. School of Medicine, Emory University, Clifton Road NE., 1365, Atlanta, 30322, Georgia, USA

    Henry F. Edelhauser

Rights and permissions

Reprints and permissions

Copyright information

© 2011 American Association of Pharmaceutical Scientists

About this chapter

Cite this chapter

Weiner, A.L. (2011). Refillable Devices for Therapy of Ophthalmic Diseases. In: Kompella, U., Edelhauser, H. (eds) Drug Product Development for the Back of the Eye. AAPS Advances in the Pharmaceutical Sciences Series, vol 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9920-7_13

Download citation

Publish with us

Policies and ethics

Societies and partnerships

Search

Navigation